Winner Medical300888.SZValuation Analysis
Based on the blended 10-year P/E and P/B percentiles, the stock currently sits in the “Fair Value Range” zone.
As of Oct 19, 2026, Winner Medical (300888.SZ) trades at a P/E of 22.20x, P/B of 1.50x, P/S of 1.60x, and a dividend yield of 2.49%.
Longitudinal percentile comparison: P/E sits at the 51st percentile over the trailing 10Y window (vs. 24th percentile over 3Y); P/B sits at the 14th percentile over the trailing 10Y window (vs. 28th percentile over 3Y); P/S sits at the 8th percentile over the trailing 10Y window (vs. 16th percentile over 3Y).
Cross-sectional valuation: its P/E ranks at the 41st percentile within its industry and the 29th percentile across the broader market.
Shareholder return highlight: Total Shareholder Yield is 2.49%, ranking at the 68th percentile over the trailing 20Y window.
The P/E and P/B percentiles diverge here, differing by 36.3 points — relying on either metric alone could be misleading. Relative to the broader market, its P/E shows a deeper discount than it does against industry peers. Shareholder returns here are driven almost entirely by cash dividends, with minimal contribution from buybacks. Winner Medical operates in the Textile and Apparel sector. Data refreshes weekly and is for reference only, not investment advice.
Also listed as: SHE: 300888 · SZSE: 300888 · 300888
Want the full picture on whether Winner Medical (300888.SZ) is under- or over-valued? See the full 3Y / 5Y / 10Y / 20Y P/E, P/B, P/S, Dividend Yield & Total Shareholder Yield percentile matrix and the interactive ECharts trend chart on this page.
Historical Percentiles by Metric
| Metric | Current | Market Percentile | Industry Percentile | 3Y Pctl | 5Y Pctl | 10Y Pctl | 20Y Pctl |
|---|---|---|---|---|---|---|---|
| P/E (TTM) | 22.20 | ||||||
| P/B (MRQ) | 1.50 | ||||||
| P/S (TTM) | 1.60 | ||||||
| Dividend Yield | 2.49% | ||||||
| Buyback + Div Yield | 2.49% |